Evidence map›Paper›PMID 37630222›Full record

ArticleMolecules (Basel, Switzerland)2023

Investigating Perampanel Antiepileptic Drug by DFT Calculations and SERS with Custom Spinning Cell.

Nicolò Simone Villa, Chiara Picarelli, Federica Iacoe, Chiara Giuseppina Zanchi, Paolo M Ossi, Andrea Lucotti, Matteo Tommasini

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nicolò Simone VillaDepartment of Chemistry, Materials, and Chemical Engineering "G. Natta", Politecnico di Milano, Piazza Leonardo da Vinci 32, 20133 Milano, Italy.ORCID 0000-0002-2493-7952
Chiara PicarelliDepartment of Chemistry, Materials, and Chemical Engineering "G. Natta", Politecnico di Milano, Piazza Leonardo da Vinci 32, 20133 Milano, Italy.ORCID 0009-0002-5367-8838
Federica IacoeDepartment of Chemistry, Materials, and Chemical Engineering "G. Natta", Politecnico di Milano, Piazza Leonardo da Vinci 32, 20133 Milano, Italy.
Chiara Giuseppina ZanchiDepartment of Chemistry, Materials, and Chemical Engineering "G. Natta", Politecnico di Milano, Piazza Leonardo da Vinci 32, 20133 Milano, Italy.ORCID 0000-0003-2656-7040
Paolo M OssiDepartment of Energy, Politecnico di Milano, Piazza Leonardo da Vinci 32, 20133 Milano, Italy.ORCID 0000-0001-6964-4216
Andrea LucottiDepartment of Chemistry, Materials, and Chemical Engineering "G. Natta", Politecnico di Milano, Piazza Leonardo da Vinci 32, 20133 Milano, Italy.ORCID 0000-0003-2148-1408
Matteo TommasiniDepartment of Chemistry, Materials, and Chemical Engineering "G. Natta", Politecnico di Milano, Piazza Leonardo da Vinci 32, 20133 Milano, Italy.ORCID 0000-0002-7917-426X

Funding

Ministero dell'Università e della Ricerca (Next Generation EU) HPC-PNRR initiative at Politecnico di Milano (Spoke 6)
6 · The paper itself

Abstract

SERS, a clinical practice where medical doctors can monitor the drug concentration in biological fluids, has been proposed as a viable approach to therapeutic drug monitoring (TDM) of the antiepileptic drug Perampanel. The adoption of an acidic environment during the SERS experiments was found to be effective in enhancing the spectroscopic signal. In this work, we combine SERS experiments, conducted with a custom spinning cell in controlled acidic conditions, with DFT calculations aimed at investigating the possible protonated forms of Perampanel. The DFT-simulated Raman spectra of protonated Perampanel accounts for most of the observed SERS signals, thus explaining the effective role of protonation of the analyte. Our results suggest protonation as a viable approach to fostering SERS of alkaline drugs.

Indexed as

AnticonvulsantsNitrilesDensity Functional TheoryPyridonesAnticonvulsantsNitrilesperampanelPyridonesnoise reductionquantitative SERSspinning celltherapeutic drug monitoring

Identifiers

PMID37630222
PMCPMC10459216

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.